These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation. Wright DG; Karsh J; Fauci AS; Klippel JH; Decker JL; O'Donnell JF; Deisseroth AB Blood; 1981 Sep; 58(3):451-8. PubMed ID: 7259834 [No Abstract] [Full Text] [Related]
3. The current status of therapeutic apheresis in the management of rheumatoid arthritis. Wallace DJ; Goldfinger D; Klinenberg JR Prog Clin Biol Res; 1982; 106():27-32. PubMed ID: 6757943 [No Abstract] [Full Text] [Related]
4. Lymphocytapheresis in the treatment of rheumatoid arthritis: clinical and immunological studies. Indiveri F; Rogna S; Viglione D; Pierri I; Scudeletti M; Grifoni V Int J Artif Organs; 1985 May; 8(3):147-54. PubMed ID: 3875567 [TBL] [Abstract][Full Text] [Related]
9. B lymphocyte depletion therapy with rituximab in rheumatoid arthritis. Edwards JC; Leandro MJ; Cambridge G Rheum Dis Clin North Am; 2004 May; 30(2):393-403, viii. PubMed ID: 15172048 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. 1991. Kondoh T; Hidaka Y; Katoh H; Inoue N; Saito S Ther Apher; 2000 Apr; 4(2):146-54. PubMed ID: 10805434 [No Abstract] [Full Text] [Related]
12. Factors that influence lymphocyte yields in lymphocytapheresis. Blanchette VS; McCombie NE; Rock G Transfusion; 1985; 25(3):242-5. PubMed ID: 4002308 [TBL] [Abstract][Full Text] [Related]
13. No B cells--no active RA? Advances in B cell depletion in RA--repeated therapy under conditions of clinical practice. Dörner T; Burmester GR Rheumatology (Oxford); 2007 Apr; 46(4):563-4. PubMed ID: 17337751 [No Abstract] [Full Text] [Related]
14. Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience. van Laar JM; Verburg RJ; Fibbe WE; Breedveld FC J Rheumatol Suppl; 2001 Oct; 64():25-7. PubMed ID: 11642499 [TBL] [Abstract][Full Text] [Related]
15. [Attempted elucidation of the mechanism of the clinical efficacy of lymphocytapheresis]. Yoshida H; Ito K; Uchino N Rinsho Ketsueki; 1986 Jul; 27(7):1247-50. PubMed ID: 3784003 [No Abstract] [Full Text] [Related]
16. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. Kondoh T; Hidaka Y; Katoh H; Inoue N; Saito S Artif Organs; 1991 Jun; 15(3):180-8. PubMed ID: 1867528 [TBL] [Abstract][Full Text] [Related]
17. [Clinical and immunological effects of leukapheresis therapy using cotton-wool filter for patients with rheumatoid arthritis]. Takeda M Ryumachi; 1996 Jun; 36(3):493-502. PubMed ID: 8779786 [TBL] [Abstract][Full Text] [Related]
18. Leukocytapheresis and rheumatoid arthritis: comment on the article by Hidaka et al. Wallace DJ Arthritis Rheum; 1999 Oct; 42(10):2255-6. PubMed ID: 10524704 [No Abstract] [Full Text] [Related]